½ÃÀ庸°í¼­
»óǰÄÚµå
1520515

¼¼°èÀÇ ÇコÄɾî ÀÎÁö ÄÄÇ»ÆÃ ½ÃÀå º¸°í¼­ :±â¼ú, Àü°³ ¸ðµå, ÃÖÁ¾ ¿ëµµ, Áö¿ªº°(2024-2032³â)

Healthcare Cognitive Computing Market Report by Technology, Deployment Mode, End Use, and Region 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 143 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ÇコÄɾî ÀÎÁö ÄÄÇ»ÆÃ ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 52¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ¾ÕÀ¸·Î IMARC GroupÀº 2024³âºÎÅÍ 2032³â±îÁö 16.8%ÀÇ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)À» º¸ÀÏ Àü¸ÁÀ̸ç 2032³â±îÁö 214¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù.

ÀÎÁö ÄÄÇ»ÆÃÀº Àΰ£ÀÇ »ç°í °úÁ¤À» ½Ã¹Ä·¹À̼ÇÇϱâ À§ÇØ µ¥ÀÌÅÍ ¸¶ÀÌ´× ±â¼ú, ÆÐÅÏ ÀνÄ, ÀÚ¿¬ ¾ð¾î, Àΰ£ÀÇ °¨°¢ ó¸®, ½Ã½ºÅÛ °³¼±¿¡ ÀÇÁ¸ÇÏ´Â ÀÚ±â ÇнÀ ½Ã½ºÅÛÀÔ´Ï´Ù. ¾öû³­ ¾çÀÇ µ¥ÀÌÅ͸¦ ó¸®ÇÏ¿© ƯÁ¤ Äõ¸®¿¡ ´äÇÏ°í ¸ÂÃãÇü ÀÎÅÚ¸®ÀüÆ® ±ÇÀå »çÇ×À» Á¦°øÇϸç ÀÇ»ç °áÁ¤À» Áö¿øÇÕ´Ï´Ù. »õ·Î¿î ÆÐÅÏÀ» ºÐ¼®Çϰí, ºñÁî´Ï½º ±âȸ¸¦ ã°í, Áß¿äÇÑ ÇÁ·Î¼¼½º Áß½ÉÀÇ ¹®Á¦¸¦ ½Ç½Ã°£À¸·Î ó¸®ÇÕ´Ï´Ù. ¶ÇÇÑ °ü·Ã ÄÁÅØ½ºÆ®¸¦ µû¶ó °¡Ä¡ ÀÖ´Â Á¤º¸¸¦ Á¦°øÇÏ¿© °í°´°úÀÇ »óÈ£ÀÛ¿ëÀ» °­È­ÇÕ´Ï´Ù. ÇöÀç ÀÎÁö ÄÄÇ»ÆÃÀº ÇコÄÉ¾î ºÐ¾ß¿¡¼­ ±¤¹üÀ§ÇÏ°Ô È°¿ëµÇ°í ÀÖÀ¸¸ç, °ú°Å µ¥ÀÌÅ͸¦ ÀÌ¿ëÇÏ¿© ȯÀÚ¸¦ Ä¡·áÇÏ°í °Ç°­°ú °ü·ÃµÈ ¸ðµç ¹®Á¦¸¦ ÀνÄÇϰí ÀÖ½À´Ï´Ù.

ÇコÄɾî ÀÎÁö ÄÄÇ»ÆÃ ½ÃÀå °æÇâ:

¼¼°è¿¡¼­ ¸¸¼º ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÏ´Â °ÍÀº ½ÃÀåÀ» °ßÀÎÇÏ´Â Áß¿äÇÑ ¿ä¼Ò Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ °Ç°­ÇÑ Á¶Á÷À» ¼Õ»ó½ÃŰÁö ¾Ê°í ¾Ï¼¼Æ÷¸¦ Á¦°ÅÇÏ´Â À¯ÀüÀÚ Æ¯ÀÌÀû Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. À̰ÍÀº ¼¼°èÀÇ °Ç°­ °ü¸® »ê¾÷ÀÇ ¹ßÀü°ú ÇÔ²² ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ´õ ³ªÀº ȯÀÚ °ü¸®¸¦ ÃËÁøÇϱâ À§ÇØ ¼¼ ¹øÂ° ÄÄÇ»ÆÃ Ç÷§ÆûÀÇ »ç¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. À̰ÍÀº Á¾¾çÇп¡¼­ °³ÀÎÈ­ Ä¡·á ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¾÷°è ÅõÀÚÀڵ鿡°Ô À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ ¿Ü¿¡µµ ÇコÄɾî ÀÎÁö ÄÄÇ»ÆÃÀº ¸ÂÃãÇü ÀÇ·á, Èæ»ö Á¾ °ËÁø ¹× ÀüÀÚ ÀÇ·á ±â·Ï(EHR) µ¥ÀÌÅÍ ºÐ¼®¿¡ Àû¿ëµË´Ï´Ù. °Ô´Ù°¡, ¼¼°èÀÇ ÀǾàǰ ¹× ÀÓ»ó½ÃÇèÀÇ ºñ¿ë Áõ°¡´Â ÇコÄɾî ÀÎÁö ÄÄÇ»ÆÃ ¼ö¿ä¸¦ ÀÚ±ØÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ ÀϺΠ±¹°¡ÀÇ ÇàÁ¤ ´ç±¹Àº ÀüÀÚ °Ç°­ ±â¼úÀÇ »ç¿ëÀ» ÃËÁøÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ½ÃÀå ±â¾÷Àº ÀμöÇÕº´(M&A)¿¡ ÁÖ·ÂÇϰí ÀÖÀ¸¸ç Àü¹ÝÀûÀÎ ¼öÀͼºÀ» ³ôÀÏ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

  • 2023³â ¼¼°èÀÇ ÇコÄɾî ÀÎÁö ÄÄÇ»ÆÃ ½ÃÀå ±Ô¸ð´Â?
  • 2024-2032³â ¼¼°èÀÇ ÇコÄɾî ÀÎÁö ÄÄÇ»ÆÃ ½ÃÀåÀÇ ¿¹»ó ¼ºÀå·üÀº?
  • ¼¼°èÀÇ ÇコÄɾî ÀÎÁö ÄÄÇ»ÆÃ ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâÀº?
  • ¼¼°èÀÇ ÇコÄɾî ÀÎÁö ÄÄÇ»ÆÃ ½ÃÀåÀ» °ßÀÎÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?
  • ¼¼°èÀÇ ÇコÄɾî ÀÎÁö ÄÄÇ»ÆÃ ½ÃÀåÀÇ ±â¼úº° ³»¿ªÀº?
  • ¼¼°èÀÇ ÇコÄɾî ÀÎÁö ÄÄÇ»ÆÃ ½ÃÀåÀÇ Àü°³ ¸ðµåº° ³»¿ªÀº?
  • ¼¼°èÀÇ ÇコÄɾî ÀÎÁö ÄÄÇ»ÆÃ ½ÃÀåÀÇ ÃÖÁ¾ ¿ëµµº° ³»¿ªÀº?
  • ¼¼°èÀÇ ÇコÄɾî ÀÎÁö ÄÄÇ»ÆÃ ½ÃÀåÀÇ ÁÖ¿ä Áö¿ªÀº?
  • ¼¼°èÀÇ ÇコÄɾî ÀÎÁö ÄÄÇ»ÆÃ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷/±â¾÷Àº?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»çÀÇ ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • »óÇâ½Ä Á¢±Ù
    • ÇÏÇâ½Ä Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

  • °³¿ä
  • ÁÖ¿ä ¾÷°è µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ÇコÄɾî ÀÎÁö ÄÄÇ»ÆÃ ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ºÐ¼® : ±â¼úº°

  • ÀÚ¿¬¾ð¾îó¸®
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ¸Ó½Å·¯´×
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ÀÚµ¿Ãß·Ð
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ±âŸ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦7Àå ½ÃÀå ³»¿ª: Àü°³ ¸ðµåº°

  • ¿ÂÇÁ·¹¹Ì½º
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • Ŭ¶ó¿ìµå ±â¹Ý
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦8Àå ½ÃÀå ºÐ¼®: ÃÖÁ¾¿ëµµº°

  • º´¿ø
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ÀǾàǰ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ÀÇ·á±â±â
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • º¸Çè
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ±âŸ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦9Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ºÐ¼® : ±¹°¡º°
    • ½ÃÀå ¿¹Ãø

Á¦10Àå SWOT ºÐ¼®

  • °³¿ä
  • °­Á¡
  • ¾àÁ¡
  • ±âȸ
  • À§Çù

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå Porter's Five Forces ºÐ¼®

  • °³¿ä
  • ±¸¸ÅÀÚÀÇ Çù»ó·Â
  • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
  • °æÀïµµ
  • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦13Àå °¡°Ý ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Apixio(Centene Corporation)
    • Apple Inc.
    • CognitiveScale
    • Enterra Solutions LLC
    • Google LLC(Alphabet Inc.)
    • Healthcare X.0 GmbH
    • Intel Corporation
    • International Business Machines Corporation
    • MedWhat
    • Microsoft Corporation
BJH 24.08.21

The global healthcare cognitive computing market size reached US$ 5.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 21.4 Billion by 2032, exhibiting a growth rate (CAGR) of 16.8% during 2024-2032.

Cognitive computing is a self-learning system that relies on data mining techniques, pattern recognition, natural languages, human sense processing, and system refinements to simulate the human thought process. It processes enormous amounts of data to answer specific queries, gives customized intelligent recommendations and supports decision making. It analyzes emerging patterns, spots business opportunities and handles critical process-centric issues in real-time. It also enhances customer interactions by providing relevant, contextual and valuable information. At present, cognitive computing is extensively utilized in the healthcare sector to treat patients using past data and recognize any health-related issues.

Healthcare Cognitive Computing Market Trends:

The growing prevalence of chronic diseases across the globe represents one of the key factors driving the market. Moreover, there is a rise in the demand for gene-specific treatment to eliminate cancer cells without damaging healthy tissues. This, along with advancements in the healthcare industry around the world, is propelling the growth of the market. In addition, there is an increase in the use of third computing platforms to facilitate better patient care. This, coupled with the escalating demand for personalized treatments in oncology, is offering lucrative growth opportunities to industry investors. Besides this, healthcare cognitive computing finds application in customized medicine, melanoma screening, and electronic health record (EHR) data analysis. Additionally, the increasing cost of drug discovery and clinical trials worldwide are catalyzing the demand for healthcare cognitive computing. Apart from this, governing authorities of several countries are undertaking initiatives to promote the usage of e-health technologies, which is positively influencing the market. Furthermore, key market players are focusing on mergers and acquisitions (M&A), which is projected to bolster their overall profitability.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global healthcare cognitive computing market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on technology, deployment mode and end use.

Breakup by Technology:

Natural Language Processing

Machine Learning

Automated Reasoning

Others

Breakup by Deployment Mode:

On-premises

Cloud-based

Breakup by End Use:

Hospitals

Pharmaceuticals

Medical Devices

Insurance

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Apixio (Centene Corporation), Apple Inc., CognitiveScale, Enterra Solutions LLC, Google LLC (Alphabet Inc.), Healthcare X.0 GmbH, Intel Corporation, International Business Machines Corporation, MedWhat and Microsoft Corporation.

Key Questions Answered in This Report

  • 1. What was the size of the global healthcare cognitive computing market in 2023?
  • 2. What is the expected growth rate of the global healthcare cognitive computing market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global healthcare cognitive computing market?
  • 4. What are the key factors driving the global healthcare cognitive computing market?
  • 5. What is the breakup of the global healthcare cognitive computing market based on the technology?
  • 6. What is the breakup of the global healthcare cognitive computing market based on the deployment mode?
  • 7. What is the breakup of the global healthcare cognitive computing market based on end use?
  • 8. What are the key regions in the global healthcare cognitive computing market?
  • 9. Who are the key players/companies in the global healthcare cognitive computing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Healthcare Cognitive Computing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Natural Language Processing
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Machine Learning
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Automated Reasoning
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Deployment Mode

  • 7.1 On-premises
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cloud-based
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmaceuticals
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Medical Devices
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Insurance
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Apixio (Centene Corporation)
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Apple Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 CognitiveScale
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Enterra Solutions LLC
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Google LLC (Alphabet Inc.)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 Healthcare X.0 GmbH
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Intel Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 International Business Machines Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 MedWhat
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Microsoft Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦